Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Medicines 201'

Medicines 201 published presentations and documents on DocSlides.

B2 How medicines can be

B2 How medicines can be

  • liane-varnes
  • 0 Slides

sustainably and equitably financed. Summary Discu...

Overview of the African Medicines Regulatory

Overview of the African Medicines Regulatory

  • celsa-spraggs
  • 0 Slides

Harmonization and . African Medicines Agency. Mar...

The Future of HIV Treatment

The Future of HIV Treatment

  • myesha-ticknor
  • 0 Slides

Greg Perry. Melbourne – International AIDS Conf...

Improving access to medicines through local production:

Improving access to medicines through local production:

  • luanne-stotts
  • 0 Slides

Some New Development. I P C Meeting, Copenhagen (...

Local Production and A ccess to Medicines

Local Production and A ccess to Medicines

  • ellena-manuel
  • 0 Slides

EMP - Technical Briefing Seminar. . 1 November, ...

Review evidence to inform the health benefits package reform

Review evidence to inform the health benefits package reform

  • lois-ondreau
  • 0 Slides

in Vietnam. 1. Waranya Rattanavipapong. Yot Teera...

The International Pharmacopoeia

The International Pharmacopoeia

  • kittie-lecroy
  • 0 Slides

Dr Herbert Schmidt. Technologies, Standards and N...

Medicines benefits management policies and programs: updates

Medicines benefits management policies and programs: updates

  • giovanna-bartolotta
  • 0 Slides

Emmanuel Kwesi Eghan . Center . for Pharmaceutica...

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

  • natalia-silvester
  • 0 Slides

V. . Habiyambere. , . J. . Perriëns. , B. Dongmo...

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

  • tawny-fly
  • 0 Slides

T.U. . Federation of Chemical, Glass and Ceramic....

Regulatory capacity building and NDRA approvals of prequalified

Regulatory capacity building and NDRA approvals of prequalified

  • celsa-spraggs
  • 0 Slides

products. Milan . Smid. . Prequalification team ...

Opportunities & Challenges:

Opportunities & Challenges:

  • pasty-toler
  • 0 Slides

Expanding Access to Hepatitis C Treatment . Gregg...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

  • cheryl-pisano
  • 0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Procurement is a hot topic!

Procurement is a hot topic!

  • pamella-moone
  • 0 Slides

So is Supply Management – but for today we will...

WHO Prequalification Team – Need and contribution

WHO Prequalification Team – Need and contribution

  • debby-jeon
  • 0 Slides

Wednesday, 5 November . 2014. 13:35 – 15:45 . W...

An introduction to the work of Australia’s regulator of therapeutic goods

An introduction to the work of Australia’s regulator of therapeutic goods

  • luanne-stotts
  • 0 Slides

Therapeutic Goods Administration. Overview. Why d...

Developing Better Medicines at Lower

Developing Better Medicines at Lower

  • luanne-stotts
  • 0 Slides

Costs: The . Good Pharma Model. Speaker:. Donald ...

NEPAD Planning and Coordinating Agency

NEPAD Planning and Coordinating Agency

  • lois-ondreau
  • 0 Slides

Multiple-Stakeholder Partnerships for Medicines B...

Dr Samvel Azatyan Group Lead

Dr Samvel Azatyan Group Lead

  • lindy-dunigan
  • 0 Slides

Capacity Building and Harmonization Support. Regu...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

The Problem of Substandard Medicines in Developing Countries

The Problem of Substandard Medicines in Developing Countries

  • pasty-toler
  • 0 Slides

By Laura Christian, Linda Collins, . Maythiwan. ...

Prequalification as a Gateway to Global

Prequalification as a Gateway to Global

  • alida-meadow
  • 0 Slides

Markets. & . Performance of WHO . Prequalific...

Medicines Adaptive Pathways to Patients (MAPPs):

Medicines Adaptive Pathways to Patients (MAPPs):

  • debby-jeon
  • 0 Slides

Saving Time, Saving Lives. Thursday, 4 June 2015,...

Unit One Pre-test A Million Dollars Activity

Unit One Pre-test A Million Dollars Activity

  • min-jolicoeur
  • 0 Slides

Drug. What do you think of when you hear the word...

Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat

Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat

  • stefany-barnette
  • 0 Slides

L Breenª, H Zaman, A Mahmood, W Nabi, F . Mansoo...

CDI Module 14: Supply Chain Management for CDI

CDI Module 14: Supply Chain Management for CDI

  • pasty-toler
  • 0 Slides

©Jhpiego Corporation. The Johns Hopkins Universi...

CDI Module 14: Supply Chain Management for CDI

CDI Module 14: Supply Chain Management for CDI

  • danika-pritchard
  • 0 Slides

©Jhpiego Corporation. The Johns Hopkins Universi...

Moving Beyond Inpatient

Moving Beyond Inpatient

  • trish-goza
  • 0 Slides

e-Prescribing . – What Comes Next?. Kandarp Tha...

Local Production and A ccess to Medicines

Local Production and A ccess to Medicines

  • debby-jeon
  • 0 Slides

EMP - Technical Briefing Seminar. . 1 November, ...

The Problem of Substandard Medicines in Developing Countries

The Problem of Substandard Medicines in Developing Countries

  • cheryl-pisano
  • 0 Slides

By Laura Christian, Linda Collins, . Maythiwan. ...

Universal Coverage… “Pharmaceutical

Universal Coverage… “Pharmaceutical

  • myesha-ticknor
  • 0 Slides

B. enefit Management” or “Pharmacy . Benefit ...

Pooled Procurement and Other Strategies to Secure Drug Supply at the Lowest Cost for IOP Clinics

Pooled Procurement and Other Strategies to Secure Drug Supply at the Lowest Cost for IOP Clinics

  • giovanna-bartolotta
  • 0 Slides

Michele Forzley, JD, MPH. December 16, 2003. St. ...

Introduction to FMD Implementing the EU Falsified Medicines Directive in the UK

Introduction to FMD Implementing the EU Falsified Medicines Directive in the UK

  • pasty-toler
  • 0 Slides

[INSERT DATE HERE]. [NAME OF PRESENTER]. [TITLE O...

Update on the Affordable Medicines Facility-malaria (AMFm) /

Update on the Affordable Medicines Facility-malaria (AMFm) /

  • min-jolicoeur
  • 0 Slides

Private Sector Co-payment Mechanism for ACTs. Int...

Ravimite regulatsioon

Ravimite regulatsioon

  • alexa-scheidler
  • 0 Slides

ja. . kättesaadavus. –. Globaalne. . kontek...

Medicines and drugs D2: Antacids

Medicines and drugs D2: Antacids

  • celsa-spraggs
  • 0 Slides

D8: Drug Action. D2: Antacids. D.2.1: State and e...

Business environment for

Business environment for

  • trish-goza
  • 0 Slides

WHO . prequalified. . medicines. Arab Union of t...

Global Cooperation for IP and

Global Cooperation for IP and

  • stefany-barnette
  • 0 Slides

Development. Esteban Burrone. Head of Policy. Med...

AMR and appropriate use of antimicrobials

AMR and appropriate use of antimicrobials

  • jane-oiler
  • 0 Slides

Nicola . Magrini. and Jane Robertson. Policy, Ac...

United Spinal Association

United Spinal Association

  • alida-meadow
  • 0 Slides

August, 2014. Biologics & Biosimilars: . An O...

Copyright © 2024 DocSlides. All Rights Reserved